Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Sep 7.

Published in final edited form as: Pancreas. 2010 Oct;39(7):964–966. doi: 10.1097/MPA.0b013e3181db01a8

TABLE 1.

Summary of Patient Characteristics

	Female (n = 43)			Male (n = 39)
Variables	Mean (SD)	Min	Max	Mean (SD)	Min	Max
Weight, kg	69.7(15.7)	48.53	120.20	87.8 (16.4)	60.78	128.37
Height, m	1.6(0.1)	1.45	1.80	1.8 (0.1)	1.55	1.88
BMI, kg/m²	26.1 (5.1)	17.79	39.13	28.6 (6.5)	18.69	49.5
LAR dose, mg/mo	44.0(21.8)	20.0	120.0	53.6 (30.2)	20.0	120.0
Plasma octreotide, pg/mL	4943.7 (4100.3)	569.0	18,495.0	4201.0 (4033.3)	100.0	19,042.0
In (Plasma octreotide)^*	8.2 (0.8)	6.34	9.83	7.9 (1.0)	4.61	9.85

^*

Natuxal log-transformed plasma octreotide.

Max indicates maximum; min, minimum.